UH
BMY icon

Unigestion Holding’s Bristol-Myers Squibb BMY Stock Holding History

Unigestion Holding’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-226,859
Closed -$11.6M – 159
2024
Q2 		$11.6M Buy
226,859
+163,420
+258% +$7.31M 0.64% 52
2024
Q1 		$3.44M Sell
63,439
-163,420
-72% -$8.32M 0.17% 79
2023
Q4 		$11.6M Sell
226,859
-251,230
-53% -$13.2M 0.64% 52
2023
Q3 		$27.7M Sell
478,089
-25,263
-5% -$1.55M 1.7% 21
2023
Q2 		$32.2M Sell
503,352
-48,656
-9% -$3.26M 1.86% 19
2023
Q1 		$37.6M Buy
552,008
+131,310
+31% +$9.26M 2.04% 14
2022
Q4 		$30.3M Buy
420,698
+38,589
+10% +$2.91M 1.61% 21
2022
Q3 		$27.4M Buy
382,109
+149,183
+64% +$10.8M 1.59% 20
2022
Q2 		$17.9M Buy
232,926
+40,432
+21% +$3.08M 1% 33
2022
Q1 		$14.1M Buy
192,494
+61,208
+47% +$4.11M 0.6% 45
2021
Q4 		$8.19M Sell
131,286
-103,240
-44% -$6.06M 0.33% 62
2021
Q3 		$13.9M Sell
234,526
-26,039
-10% -$1.71M 0.56% 46
2021
Q2 		$17.3M Sell
260,565
-440,577
-63% -$28.7M 0.62% 48
2021
Q1 		$44.3M Sell
701,142
-206,963
-23% -$12.9M 1.57% 26
2020
Q4 		$56.3M Buy
908,105
+769
+0.1% +$47.3K 1.93% 22
2020
Q3 		$54.7M Sell
907,336
-55,168
-6% -$3.32M 1.88% 24
2020
Q2 		$56.6M Buy
962,504
+909,467
+1,715% +$54.4M 1.91% 17
2020
Q1 		$2.95M Buy
+53,037
New +$3.24M 0.11% 108
2019
Q1 		– Sell
-422,027
Closed -$21.9M – 253
2018
Q4 		$21.9M Sell
422,027
-38,839
-8% -$2.09M 0.55% 65
2018
Q3 		$28.6M Sell
460,866
-230,132
-33% -$13.7M 0.6% 62
2018
Q2 		$38.2M Buy
+690,998
New +$37.3M 0.76% 46

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Unigestion Holding's BMY Position: Q3 2024 in Review

Unigestion Holding sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 226,859 shares — an estimated $11.6M sold.

Unigestion Holding first reported a position in BMY in Q2 2018 and held it in 21 quarters. The position peaked at $56.6M in Q2 2020. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Unigestion Holding reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Unigestion Holding sold 226,859 Bristol-Myers Squibb shares in Q3 2024, an estimated $11.6M.
  • Unigestion Holding first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 21 quarters.
  • Unigestion Holding's Bristol-Myers Squibb position peaked at $56.6M in Q2 2020.
  • 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Unigestion Holding's 13F filing for Q3 2024, filed 19 Nov 2024.